About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials | 3,993 Studies Recruiting

Clinical TrialsCOVID-19

COVID-19 Clinical Trials

Browse 3,993 clinical trials for covid-19. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1221-1240 of 3,993 trials

CompletedPREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUSThis is a phase 3 clinical trial, randomized, single-center, opened, controlled, to evaluate efficacy and safety of early administration of colchicines in patients older than 60…NCT04416334·Laredo, Cantabria and 3 others CompletedConvalescent Plasma in Pediatric COVID-19COVID-19 is increasingly affecting children but convalescent plasma (CP) has not been adequately studied in children to date.NCT04458363·Atlanta, Georgia CompletedMass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) AntibodiesDESIGN Observational epidemiological study AIMS - To determine: 1.NCT05148806·Bristol and 3 others UnknownPrognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 PatientsThis study will evaluate the associations between vascular parameters and clinical outcomes in patients hospitalized with COVID-19.NCT04714125·São Paulo

Related Searches

covid-19trials coronavirustrials sars-cov-2trials

Data from ClinicalTrials.govTerms

Active not recruitingImmunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy VolunteersThe immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/dose/Vial) administered as a booster in healthy adults aged 19 years old and above will be evaluated.NCT05993325·Iloilo City and 16 others

CompletedCOVID-19 Anosmia StudyTo capture the natural history of COVID-19 associated olfactory dysfunction as measured by two patient reported outcome measures (SNOT-22, QOD-NS) and a 6-week BSIT with a…NCT04495816·New York, New York

UnknownA Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) StudyThe study is designed as a randomized, controlled, multi-center open-label trial to compare standard-of-care (SOC) treatment with SOC + anakinra or SOC + tocilizumab treatment in…NCT04412291·Huddinge, Stockholm County

CompletedComparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid FibrosisRehabilitation plays a very important role in the management of patients with COVID-19, focusing on respiratory and motor functions, and therefore the importance of establishing…NCT05299333·Istanbul

CompletedLong COVID-19 Cutaneous Signatures: An ARPA Funded Research ProjectThis is a prospective, longitudinal study involving 300 participants for a single visit to compare Long COVID-19 neurocutaneous biosignatures with those of other disorders…NCT07005947·Scottsdale, Arizona

CompletedSARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.NCT04487197·Milan

CompletedEffects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized PatientsThe purpose of this study assess the efficacy and safety of anti-SARS-CoV-2 convalescent plasma in hospitalized patients with acute respiratory symptoms up to 14 days after the…NCT04421404·San Francisco, California and 2 others

Active not recruitingInvestigating the Effectiveness of VimidaThis randomized controlled trial (RCT) with 160 patients suffering from fatigue after COVID-19 infection aims to investigate the effectiveness of the unguided digital therapeutic…NCT06251518·Hamburg

CompletedDigital Multimodal Rehabilitation for People With Post-acute COVID-19 Syndrome.Although most infected people survive the infection, many have persistent sequelae or symptoms, which cause disability or decreased quality of life.NCT05846126·Terrassa

CompletedBREATHE: Virtual Self-management for Long COVID-19A mixed-methods evaluation of a virtual self-management program for people living with long COVID in Alberta.NCT05107440·Calgary, Alberta

CompletedBooster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)This study is a continuation study of the original V-01-I phase trial, using a single-center, single-arm, open design to evaluate the immunogenicity and safety of the third dose…NCT05050474·Guangzhou, Guangdong

CompletedHydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare WorkersIn order to assess the efficacy of hydroxychloroquine treatment weekly for a total of 7 weeks in the prevention of COVID-19 infection, three hundred sixty (360) Healthcare workers…NCT04333225·Dallas, Texas

TerminatedhCT-MSCs for COVID19 ARDSThis is a 50 patient, Phase 1/2a multi-center pilot study to test the safety and to describe the preliminary efficacy of intravenous administration of allogenic human cord tissue…NCT04399889·Boca Raton, Florida and 4 others

CompletedReliability (Test-retest) of 30 Seconds Sit-to-stand and Timed Up and Go in Adults With Long CovidThe goal of this study is to test the reliability (with a test-retest process) of 30 seconds Sit to Stand and Timed Up and Go in an adult population with long-covid, hospitalised…NCT05886842·Larnaca

TerminatedSafety and Efficacy of Melatonin in Outpatients Infected With COVID-19This study is a pilot randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of melatonin in adult outpatients suspected to be afflicted…NCT04474483·Buffalo, New York

CompletedImpact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19The IMPACT-SIRIO 5 is a randomized, double-blind, phase III clinical trial aimed to evaluate safety and efficacy of PCSK9 inhibition on clinical outcome in patients during the…NCT04941105·Bydgoszcz

PreviousPage 62 of 200Next